Peripartum Cardiomyopathy

( Lancet . 2025;406(10518):2483–2493. doi:10.1016/S0140-6736(25)01451-5) Peripartum cardiomyopathy (PPCM) is a serious and potentially fatal form of heart failure that develops toward the end of pregnancy or in the months following delivery in women with no prior history of heart disease. Over the past 2 decades, increased recognition and research have substantially advanced understanding of its causes, diagnosis, and management. The condition is defined by the presence of left ventricular systolic dysfunction, typically an ejection fraction below 45%, after exclusion of alternative explanations such as congenital, valvular, or pre-existing cardiomyopathies. Despite therapeutic progress, PPCM remains associated with significant maternal and neonatal morbidity and mortality, and only about half of affected women experience full recovery of cardiac function within 6 months.

Authors

Publication Details

Journal
Obstetric Anesthesia Digest
Published
2026-11-18
DOI
https://doi.org/10.1097/01.aoa.0001288924.55214.de
Primary Topic
Cardiovascular Issues in Pregnancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peripartum Cardiomyopathy

Sonel Goland, MR Johnson, K Sliwa, J Bauersachs et al.
Obstetric Anesthesia Digest
Cardiovascular Issues in Pregnancy
article

Peripartum Cardiomyopathy

Sonel Goland, MR Johnson, K Sliwa, J Bauersachs, A Damasceno, H Al Farhan, D Hilfiker-Kleiner
article en

Abstract

( Lancet . 2025;406(10518):2483–2493. doi:10.1016/S0140-6736(25)01451-5) Peripartum cardiomyopathy (PPCM) is a serious and potentially fatal form of heart failure that develops toward the end of pregnancy or in the months following delivery in women with no prior history of heart disease. Over the past 2 decades, increased recognition and research have substantially advanced understanding of its causes, diagnosis, and management. The condition is defined by the presence of left ventricular systolic dysfunction, typically an ejection fraction below 45%, after exclusion of alternative explanations such as congenital, valvular, or pre-existing cardiomyopathies. Despite therapeutic progress, PPCM remains associated with significant maternal and neonatal morbidity and mortality, and only about half of affected women experience full recovery of cardiac function within 6 months.

Obstetric Anesthesia DigestVol. 46(4)
Good health and well-being
Cardiovascular Issues in Pregnancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon